In this proposed study, Erbium (Er3+)-doped ZnO nanocomposites were prepared through the effective, basic, and green combustion method. The significant effects of Er-dopants on the structural, morphological features, dielectric and optical behaviors of the pure ZnO matrix as well as Er2O3–ZnO nanostructured materials were investigated applying X-ray diffraction (XRD), scanning electron microscopy (SEM), Fourier transformation Infrared spectroscopy (FTIR), and UV–Vis spectrophotometer techniques. These results showed that the synthesized Er2O3–ZnO nanocomposites are well polycrystalline. The Er2O3–ZnO nanocomposites are almost uniformly distributed on the surface morphologies. Furthermore, UV-Vis diffuse reflectance spectroscopy, AC electrical conductivity, and dielectric properties' current-voltage characteristics were utilized to examine the influence of erbium-doping on the optical properties, energy bandgaps of the proposed Er2O3–ZnO nanostructured powder. The tested nano-samples were applied for the visible light photodegradation of p-chlorophenol (4-CP) and p-nitrophenol (4-NP). The Er-doped ZnO ratio affects the photocatalytic activity of the ZnO matrix. This current research substantiated that more than 99.5% of 4-CP and 4-NP were photodegraded through 30 min of irradiation. Four times, the Er: ZnO nanocatalysts were used and still displayed an efficiency of more than 96.5% for 4-CP and 4-NP degradations in the specified period = 30 min. The as-prepared Er2O3-ZnO nanostructured are considered novel potential candidates in broad nano-applications from visible photocatalytic degradation of waste pollutants to the electronic varistor devices.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.